Category: Shroom Boom
-
![Compass Pathways (CMPS.Q) is rubbing investors the wrong way, again]()
Compass Pathways (CMPS.Q) is rubbing investors the wrong way, again
Cut the kumbaya shit Throwing the words profit and psychedelic drugs into a sentence would have lead to awkward and confused looks 5 years ago. But we have come a long way, and in that process, questions have arisen like: how do money and psychedelics mix? Psychedelic medicine advocates who have never been around the…
-
Canntab (PILL.C) yeets another patent for hard-pressed, long release cannabis pills
I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature space that more and more adults are making use of, and that is free to innovate, free to be excellent, free to market itself properly, and…
-
![Delic Holdings (DELC.C) to acquire industry leading ketamine clinics as plan becomes clearer]()
Delic Holdings (DELC.C) to acquire industry leading ketamine clinics as plan becomes clearer
Regular readers with an interest in psychedelics will know we recently started talking to a company called Delic Holdings (DELC.C), and that it was a company coming to the market, not claiming it had the answers to profitability in a competitive space, or that it would lead the world in this or that but, rather,…
-
![Xphyto’s (XPHY.C) lays out its ambitious Parkinson’s/Epilepsy/Depression/Multiple Sclerosis drug formulation strategy which includes heavy investment in psychedelic medicine]()
Xphyto’s (XPHY.C) lays out its ambitious Parkinson’s/Epilepsy/Depression/Multiple Sclerosis drug formulation strategy which includes heavy investment in psychedelic medicine
Xphyto describes itself as “a bioscience accelerator” “targeting growth through commercialization of its product pipeline”.
-
![Canntab Therapeutics (PILL.C): The Canadian weed sector is struggling, but new consumer products have room to scale]()
Canntab Therapeutics (PILL.C): The Canadian weed sector is struggling, but new consumer products have room to scale
If we’re honest about it – if we’re REALLY honest about it – Canada has fumbled its advantage in the cannabis sector. First to market, first to raise hundreds of millions in financing, first to legalize, first to recreationalize (not a word but I’m on a roll), and it’s all really been for naught. In…
-
![Xphyto Therapeutics (XPHY.C) lays out their milestones and strategic guard-rails for 2021]()
Xphyto Therapeutics (XPHY.C) lays out their milestones and strategic guard-rails for 2021
In lieu of the American markets not opening today courtesy of the civic holiday, Xphyto Therapeutics (XPHY.C) has elected to provide a glimpse into their business strategy and milestones for 2021. As an overview, the company sees itself on the edge of a transformational change as their product development programs go from the laboratory to…
-
Does Core One Labs (COOL.C) have a solution for psilocybin’s dosing problem?
Core One’s objective in developing the psilocybin thinstrips is to assist with the delivery of revolutionary psychedelic treatment methods to address mental health conditions such as depression, anxiety and addictions.
-
![Delic (DELC.C) adds Hollywood legend to psychedelic advisory board]()
Delic (DELC.C) adds Hollywood legend to psychedelic advisory board
The company’s platform includes “The Delic”, an e-commerce lifestyle brand, “Reality Sandwich”, a free public education platform and “Meet Delic” – a psychedelic wellness summit with its first planned event on May 1, 2021 in Los Angeles.
-
Core One Labs (COOL.C) acquires 100% of a synthetic psilocybin company
“This transaction will significantly enhance Core One Labs’ ability to innovate our psychedelic drug development program,” stated Joel Shacker, CEO of Core Labs.
-
![The mushroom market roundup – who to look out for in 2021 featuring TRIP.C, MMED.E, XPHY.C, NUMI.V, and PULL.C]()
The mushroom market roundup – who to look out for in 2021 featuring TRIP.C, MMED.E, XPHY.C, NUMI.V, and PULL.C
The notion of magic mushroom market offering after the legalization of cannabis has been floated time and again since long before cannabis legalization was even on the table. It would be late night at parties among my older friends who after they finished their mandatory rant on how cannabis should be legalized and regulated and…
